MigraineScience

 Learn how migraine increases stroke risk and discover evidence-based prevention strategies from the latest AHA/ASA guidelines. Practical tips on diet, exercise, medication, and hormonal considerations specifically for migraine patients. Essential...

Key findings from current research on how chronic migraine affects brain structure and function, recent neuroimaging advances, and associated comorbidities.

Discover how treating subclinical hypothyroidism with low-dose levothyroxine may reduce migraine frequency by 28%. Learn about TSH levels, treatment guidelines, and when intervention is recommended.

Fremanezumab (Ajovy) for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder Findings from the UNITE randomized clinical trial involving 353 patients with both migraine and depression Based...

New research reveals increased cerebral blood flow in migraine patients between attacks. This 4D flow MRI study shows significant hemodynamic changes in the middle and posterior cerebral arteries, with blood...

Discover how migraine affects pregnancy outcomes: New meta-analysis reveals increased risks of preeclampsia and preterm birth. Essential reading for patients and clinicians.

Discover how migraine increases cardiovascular disease risk by 12%, with young women facing 60% higher risk. Learn about the significant interaction between migraine and lifestyle factors that could impact heart...

Is Botox (OnabotulinumtoxinA) safe for pregnant migraine sufferers? Review current research, FDA classification, and clinical recommendations for using Botox injections during pregnancy and breastfeeding. Learn about safety data from studies...

Comprehensive expert guide to migraine treatments: evidence-based recommendations for acute medications (NSAIDs, triptans, gepants), preventive therapies, and special considerations for pregnancy, cardiovascular disease, and other medical conditions. Find effective strategies...

Discover evidence-based guidelines for migraine treatment from leading experts. Learn about effective medications for acute attacks and prevention, their evidence quality, and recommendation strength to better manage your migraines.

Discover key predictors of Aimovig (erenumab) response in migraine patients. This REFORM study reveals which patients benefit most from CGRP therapy and why timing matters. Evidence-based insights for better treatment...

STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.

Groundbreaking research reveals how migraine patients process visual information differently. This 2025 study found that migraine patients take longer to process simple visual stimuli compared to complex images, which is...

In a development for migraine patients, the FDA has granted marketing authorization to CT-132, making it the first prescription digital therapeutic specifically designed for the preventive treatment of episodic migraine...

This meta-analysis found that weather conditions, especially temperature and ambient pressure changes as well as increased levels of certain air pollutants (PM10, PM2.5, NO2, CO, and O3), are significantly associated...